LEO 90100 foam

DRUG3 trials

Sponsors

LEO Pharma

Conditions

HealthyPsoriasis Vulgaris

Phase 1

Skin Irritation of LEO 90100 Foam (Calcipotriol Hydrate Plus Betamethasone Dipropionate) in Healthy Japanese Subjects

CompletedNCT03442244

LEO PharmaPsoriasis Vulgaris

Start: 2018-01-30End: 2018-02-20Updated: 2025-02-24

Dermatopharmacokinetic Trial of LEO 90100 Foam

CompletedNCT03476746

LEO PharmaHealthy

Start: 2018-03-20End: 2018-07-01Updated: 2025-02-24

Phase 3

Efficacy and Safety of LEO 90100 Foam in Japanese Subjects With Psoriasis Vulgaris

CompletedNCT03806790

LEO PharmaPsoriasis Vulgaris

Start: 2019-01-24End: 2019-06-10Updated: 2025-03-10